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INTRODUCTION: 
Helicobacter pylori, one of the most common bacteria, 
and are capable of colonizing the hostile environment of 
the human stomach and are capable of causing peptic 
ulcers. There are other micro organisms which can 
cause serious stomach specific infections, namely 
Klebsiella, Salmonella, some harmful strains of E.coli, 
Streptococcus etc
1
. Many antibacterial agents have been 
used to treat infections caused by above pathogens, but 
different studies reveals that eradication of such 
bacterium are not efficient due to some basic hindrance 
like instability of drug in low pH of the gastric fluid, 
very low concentration of drug reaching the bacteria 
under the mucosa, short residence time of the antibiotic 
in the stomach
2
.
 
Patient compliance, side effect and 
bacterial resistance falls under the secondary problems 
for the same. One approach for effective eradication of 
H. pylori and other pathogens is to deliver the antibiotic 
locally in the stomach with better stability and longer 
residence time, which will allow more of the active 
drug to penetrate through the gastric mucus layer to act 
on infectious organism
3
. 
Floating drug delivery system (FDDS) is a novel 
approach to achieve gastric retention to obtain sufficient 
drug bioavailability. Due to less bulk density than 
gastric fluids,these systems are capable of maintaining 
their buoyancy in the stomach for a prolonged period of 
time, thus with a desired rate drug is released slowly in 
the stomach. After the drug is released, the residual 
system is emptied from the stomach
4
.  
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ABSTRACT: 
Floating drug delivery system comes with the advantage of sustained release of drugs over a prolonged period of time thereby 
maximising the oral absorption of drugs with narrow absorption window, thus, it overcomes the challenges of conventional oral 
drug delivery system. In situ gelling system is a novel approach towards this. The aim of the present work was to develop a 
novel floating in situ gelling system for sustained drug delivery of Azithromycin dihydrate for eradication of H. pylori. In situ 
gelling system were prepared by dissolving different concentrations of gelling polymers like sodium alginate, xanthan gum, 
gellan gum in deionized water at 800C. After cooling to 400C fixed amount of drug and calcium carbonate were dispersed in it 
with continuous stirring. Compatibility between drug and polymers were confirmed by FTIR studies. All formulations showed 
pH in the range of 6.4 to 6.9, drug content was found to be in the range of 97.29% to 99.27%, floating lag time was less than 1 
min, duration of floating was more than 24 h for all the prepared formulations. It was observed that the gelling capacity, 
viscosity and water uptake by the gel increased with the increase in polymer concentration. In vitro drug release was found to 
be in between 82.11% to 89.49%, up to 8 h, and the maximum drug release was shown by formulation F1. Drug release 
responded inversely with the increase in polymer concentration. The release kinetics of all the formulations followed Higuchi 
diffusion mechanism. Hence, a floating in situ gelling system of Azithromycin dihydrate could be prepared using different 
concentrations of gelling polymers to increase the patient compliance with reduced dosing frequency and increased residence 
time of drug in the stomach for better eradication of H. pylori. 
Keywords: Floating drug delivery system, Azithromycin dihydrate, H. pylori, In situ gelling system. 
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In situ gelling system is a novel approach in the FDDS. 
In situ gels which when administered are in solution 
form, but as it comes in contact with gastric fluids, it 
forms gels. The phase transition of in situ gels may be 
attributed to one or combination of different stimuli like 
ionic interaction/pH change/ temperature modulation 
and solvent exchange
5
. In situ gelling systems come 
with the advantages of ease of administration, reduced 
frequency of administration, improved patient 
compliance and comfort
6
. As the gelling capacity of the 
in situ gels increases, their residence time in the 
stomach increases which eventually leads sustains the 
delivery of the drug. 
Azithromycin dihydrate is a macrolide antibiotic used in 
the treatment of many gram negative and gram positive 
infections. It is chosen as the active drug in the present 
study to be incorporated in the in situ gelling system 
due to its low bioavailability following oral 
administration
7
; their tablet form shows low 
bioavailability around 34±19% and their stability in the 
gastric environment. Since, with a low oral 
bioavailability they are needed to be taken for several 
days to completely eradicate the infection. But the novel 
floating in situ gelling system of Azithromycin 
dihydrate will come with the advantage of increased 
gastric residence time, which eventually will result in 
prolonged drug delivery with better patient compliance 
and lesser dosing frequency. 
MATERIALS AND METHOD:  
Azithromycin dihydrate was obtained as a gift sample 
from Glow Pharma. Gellan gum was purchased from 
Rajesh chemical co. Mumbai. All other materials used 
were of analytical grade. 
Preparation of in situ gelling system:  
Sodium alginate, xanthan gum and gellan gum solutions 
of different concentrations (1.0-2.0 % w/v) were 
prepared in deionized water containing sodium citrate 
(0.45% w/v). The Sodium alginate, Xanthan gum and 
Gellan gum were dispersed in deionized water, heated 
to 60
0
C to 90
0
C with stirring and then cooled below to 
40
0
C. Fixed quantity of drug (250 mg) and calcium 
carbonate (0.05%w/v) was added after cooling the 
solution below 40
0
C with continuous stirring to form 
uniform dispersion. These prepared sols were stored at 
room temperature until further use. 
Evaluation: 
Compatibility studies:  
The drug polymer interaction studies were carried by 
FTIR technique by KBr pelletization method. The 
physical mixture of drug and polymers were taken in a 
ratio of 1:1 and mixed uniformly with demoisturized 
KBr
8
. The mixture was then compressed to a thin 
transparent pellet by subjecting to hydraulic press, 
which is then placed in the path of IR rays using a 
sample holder to record the spectra from 400 – 4000cm-
1
. 
In vitro gelation study
9
: 
 
 The in vitro gelling capacity of prepared formulations 
was measured by placing 5 ml of the gelation solution 
(0.1N HCl, pH 1.2) in a 15 ml borosilicate glass test 
tube and maintained at 37±1 
0
C temperature. 1 ml of 
formulation solution was added with the help of pipette. 
The formulation was transferred in such a way that 
places the pipette at surface of fluid in test tube and 
formulation was slowly released from the pipette. As 
the solution comes in contact with gelation solution, it 
was immediately converted into stiff gel like structure; 
the gelling capacity of solution was evaluated in the 
basis of stiffness of formed gel and time period for 
which the formed gel remains as such. The in vitro 
gelling capacity was graded in three categories on the 
basis of gelation time and time period for which the 
formed gel remains. 
(+) Gels after few minutes, dispersed rapidly. 
(++) Gelation immediately remains for few hours. 
(+++) Gelation immediate remains for an extended 
period. 
In vitro floating studies
10
:  
The in vitro floating study was determined using USP 
dissolution apparatus having 500 ml of simulated 
gastric fluid (pH 1.2). The Petri dish containing 5 ml of 
in situ gelling solution was immersed into dissolution 
apparatus (USP24) containing 500 ml of SGF (pH 1.2) 
at 37 
0
C. The time the formulation took to emerge on 
the medium surface (floating lag time) and the time the 
formulation constantly floated on the dissolution 
medium surface (duration of floating) were noted by 
visual observation. 
Determination of viscosity
9,11
:
 
Viscosity of the samples was determined using a 
Brookfield digital viscometer with spindle number 2. 
The sample temperature was controlled at 25±1 
0
C 
before each measurement. Viscosities of gels were 
determined at different shear rates from 10 to 100 rpm 
at room temperature. 
Drug Content
12
: 
 
5 ml of the solution was added to 900 ml of simulated 
gastric fluid (0.1 mol/l HCl, pH 1.2) and stirred for 1 hr 
on a magnetic stirrer. The solution was filtered, suitably 
diluted with simulated gastric fluid and the drug 
concentration was determined by using a UV-visible 
spectrophotometer at 272 nm against a suitable blank 
solution. 
Measurement of water uptake by the gel
13,14
: 
 
The water uptake by the gel of all formulations can be 
determined using a thermo-gravimetric analyzer. But in 
this present study a simple method has been adopted to 
determine the water uptake by the gel. The in situ gel 
formed in 40 ml of gastric acid buffer (pH 1.2) was 
used for this study. From each formulation the gel 
portion from the buffer was separated and the excess 
buffer was blotted out with a tissue paper. The initial 
weight of the gel taken was weighed and to this gel 10 
ml of distilled water was added and after every 30 mins 
of the interval water was decanted and the weight of the 
gel was recorded and the difference in the weight was 
calculated and reported. 
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Microbiological studies:  
Four petridish were prepared with nutrient agar medium 
using micro pipette, 0.2 ml of seeded broth containing 
test organism were spreaded uniformly. With an 
aluminium bore of 5mm diameter four wells were cut 
out on the agar media. Each well was filled with equal 
quantity of test and standard alternatively and in a zig 
zag manner. The plates were then incubated at 37±1 
0
C 
for 24 h. After the incubation period the mean diameter 
of zone of inhibition in cm obtained around the well 
were measured. Strict aseptic conditions were followed 
for the entire process
15
. 
In vitro drug Release
16
: 
 
 
The release of Azithromycin dihydrate was studied 
using USP type II dissolution apparatus containing 500 
ml of 0.1N HCl maintained at 37±0.5
0
C and stirred at 
50 rpm. Samples were collected periodically and 
replaced with a fresh dissolution medium. These 
samples were analyzed for the drug present in them 
with help of UV spectrophotometer at 215 nm. Further 
the in vitro drug release for the drug release kinetics 
like zero order (cumulative %drug release against time), 
first order release (log cumulative %drug release against 
time), Higuchi equation (cumulative %drug release 
against square root of time and Korsmeyer peppas 
model (log cumulative %drug release against log time) 
were also studied.  
RESULTS AND DISCUSSION:  
The composition of various formulations of 
Azithromycin dihydrate floating in situ gels were shown 
in table 1.  
The identification characterization of Azithromycin 
dihydrate and compatibility with different polymers 
were carried out using infrared spectroscopy from 400 
to 4000cm
-1
 using KBr pellets.  As there were no major 
changes in the peaks, indicates that there was no 
incompatibility of the drug with the polymers used in 
the formulations fig 1. 
 
Table 1: Formulation table of Azithromycin dihydrate in situ gelling system 
 
Ingredients 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
 
F8 
 
F9 
 
Azithromycin 
dihydrate 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
 
250 
mg 
Sodium Alginate 
 
1.0% 
w/v 
1.5% 
w/v 
2.0% 
w/v 
- - - 
 
- 
 
- 
 
- 
Gellan gum - - - 
1.0% 
w/v 
1.5% 
w/v 
2.0% 
w/v 
- - - 
Xanthan gum - - - - - - 
1.0% 
w/v 
1.5% 
w/v 
2.0% 
w/v 
Sodium Citrate 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
0.45% 
w/v 
Calcium 
Carbonate 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
0.50% 
w/v 
Water (q.s) 10ml 10ml 10ml 10ml 10ml 10ml      10ml 10ml    10ml 
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Figure 1: FTIR compatibility studies: (1) Azithromycin dihydrate (2) sodium alginate (3) xanthan gum (4) gellan 
gum (5) drug +polymers 
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There were almost no change in the peak regions of 
pure drug like aromatic primary amine group stretch at 
3494 cm
-1
, Methyl –CH symmetric stretch at 2973 cm-1 
and –C=O stretch at 1718 cm-1, when compared with 
the mixture of drug and polymer
16
. 
The concentration of polymers used affect the viscosity 
as well as gelling capacity. As the concentration of the 
gelling polymers were increased the viscosity of the 
formulation also increased with an increase in the 
gelling capacity
18
 as shown in table 2. 
 
Table 2: Viscosity, Floating time, Floating lag time and Gelling capacity of Azithromycin dihydrate in situ gel 
formulations  
 
Formulation 
 
Viscosity of  sol  
(cps) 
 
Viscosity of  
gel  (cps) 
 
In vitro floating 
lag time (min) 
 
In vitro floating 
time (h) 
 
Gelling 
capacity 
F1 3.5 80.6 <1 >24 ++ 
F2 5.7 84.8 <1 >24 +++ 
F3 8.2 91.1 <1 >24 +++ 
F4 4.9 85.2 <1 >24 ++ 
F5 8.9 93.3 <1 >24 +++ 
F6 11.6 98.1 <1 >24 +++ 
F7 8.3 91.2 <1 >24 ++ 
F8 8.7 91.4 <1 >24 +++ 
F9 8.9 91.8 <1 >24 +++ 
  
The amount of drug present in all formulations was 
evaluated by spectrophotometrically at 215nm. The 
results are tabulated in table 3. The drug content ranges 
from 97.92% to 99.27%. 
The water uptake by gel was directly proportional to the 
polymer concentration. As the concentration of the 
gelling polymers was increased the water uptake by the 
gel also increased. The % of water uptake by gel also 
influenced the drug release from the gel. As the of water 
uptake by gel increased the drug release was found to 
decrease
17
. The % of water uptake by gel is graphically 
shown in fig 2. 
Table 3: Drug content of Azithromycin dihydrate in 
situ gels in 0.1N HCl 
Formulations Drug Content (%) 
F1 98.52 
F2 98.84 
F3 99.16 
F4 98.76 
F5 98.85 
F6 99.27 
F7 97.29 
F8 97.99 
F9 99.09 
 
 
  
Figure 2: % of water uptake by Azithromycin dihydrate in situ gel formulations (F1-F9) 
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For the microbial studies E.coli, Klebsiella, 
Streptococcus was selected. H. pylori were not used as a 
reference micro organism because they are difficult to 
work with, make larger zone of inhibition which may 
overlap and they usually die readily. The effect was 
studied by comparing the zone of inhibition of the 
microbial growth as tabulated in table 4. The oral 
floating in situ gelling system of Azithromycin 
dihydrate was found to be effective in eradication of 
bacteria causing stomach infection
16
. 
 
Table 4: Microbial studies of various formulations of Azithromycin dihydrate floating in situ gels 
   
Formulations 
Zone of inhibition (cm) 
E.coli Klebsiella Streptococcus 
Standard drug 1.73 1.79 1.59 
F1 1.70 1.64 1.25 
F2 1.68 1.65 1.30 
F3 1.66 1.69 1.40 
F4 1.65 1.71 1.39 
F5 1.70 1.67 1.38 
F6 1.69 1.65 1.37 
F7 1.63 1.69 1.39 
F8 1.61 1.66 1.41 
F9 1.60 1.69 1.36 
 
 
 
Figure 4: Higuchi plot of Azithromycin dihydrate in situ gels formulations (F1-F9) 
 
 
                         A                                              B                                           C 
Figure 5: Photograph of formed Azithromycin dihydrate in situ gel formulations: A (F3), B (F6), C (F9) 
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The concentration of gelling polymers on in vitro drug 
release from floating in situ gels is showed in fig 3. A 
significant decrease in rate and extent of drug release is 
seen with increase in polymer concentration this pattern 
is attributed to increase in the density of the polymer 
matrix and also an increase in the diffusional path 
length which the drug molecules have to travel. With 
the increase in the concentration of gelling polymer 
decreased rate and extent of drug release with sustained 
effect was observed table 5 and fig 3. The release of 
drug from these gels was characterized by an initial 
phase of high release which is actually the burst effect
18
. 
 
 
 
Fig 3: In vitro drug release of Azithromycin dihydrate in situ gel from different gelling polymers in different 
concentrations 
Table 5: In vitro cumulative %drug release of Azithromycin dihydrate in situ gel 
Time 
(h) 
Cumulative %drug release 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
0 0 0 0 0 0 0 0 0 0 
1 40.34 38.02 34.22 40.79 38.78 35.32 41.11 40.40 39.21 
2 50.12 48.32 41.77 49.91 47.79 45.98 52.21 51.12 48.75 
3 58.88 56.21 49.91 57.82 55.81 53.16 59.85 59.88 56.63 
4 67.91 64.32 57.85 66.73 65.33 63.75 68.16 68.19 64.89 
5 75.99 73.10 66.91 74.90 72.69 71.64 75.13 76.90 73.70 
6 79.56 77.21 74.32 79.93 77.97 75.06 81.01 80.50 77.80 
7 83.92 81.15 80.22 84.22 81.99 79.77 82.89 81.97 80.16 
8 89.49 85.54 83.59 88.36 85.92 82.11 84.06 83.61 82.96 
 
In vitro drug release study for all nine prepared formulations showed sustained drug release for longer period of time 
and followed Higuchi release pattern
16 
as tabulated in table 6. 
Table 6: Release mechanism of Azithromycin dihydrate floating in situ gels 
 
Formulations 
 
Zero Order 
(R
2
 value) 
 
First Order 
(R
2
value) 
 
Higuchi Model 
(R
2
value) 
 
Peppas model 
(n values) 
F1 0.853 0.979 0.989 0.656 
F2 0.910 0.986 0.990 0.660 
F3 0.811 0.987 0.995 0.660 
F4 0.855 0.988 0.988 0.655 
F5 0.861 0.987 0.990 0.658 
F6 0.865 0.987 0.988 0.659 
F7 0.813 0.986 0.975 0.661 
F8 0.811 0.988 0.974 0.660 
F9 0.835 0.986 0.982 0.658 
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CONCLUSION:  
On the basis of obtained results and experimental 
conditions used in the study, F6 formulation showed 
sustained release of drug from the gel. The developed 
formulations met all prerequisites to become an in situ 
gelling floating system, formed and floated 
instantaneously in the pH conditions of the stomach. 
This study demonstrated that in situ gels formed by oral 
administration of solutions of gellan gum and releases 
Azithromycin dihydrate in a sustained manner over a 
period of time for at least 8h. It was observed that the 
feasibility of in vitro gel was formed form aqueous 
solutions of different gelling polymers. It can be 
concluded from the study that, increase in concentration 
of different gelling polymers decreases the release of 
drug from the prepared formulations. Thus, it can be 
concluded that the release of Azithromycin dihydrate 
could be targeted to stomach and sustain the drug 
release over a period of time. Further investigation is 
needed to prepare the best and most successful 
formulation of Azithromycin dihydrate in situ gelling 
system.  
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